Cornerstone Capital Management Holdings’s ResMed RMD Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$2.26M	Buy	26,679 +2,329	+10%	+$192K	0.02%	732
2017 Q3	$1.87M	Buy	+24,350	New	+$1.86M	0.01%	772
2017 Q1	–	Sell	-52,110	Closed	-$3.23M	–	1359
2016 Q4	$3.23M	Sell	52,110 -146,582	-74%	-$8.98M	0.02%	600
2016 Q3	$12.9M	Buy	198,692 +37,403	+23%	+$2.49M	0.1%	230
2016 Q2	$10.2M	Buy	+161,289	New	+$9.51M	0.08%	274
2015 Q4	–	Sell	-10,566	Closed	-$538K	–	1513
2015 Q3	$538K	Sell	10,566 -41,293	-80%	-$2.22M	0.01%	992
2015 Q2	$2.92M	Buy	51,859 +35,432	+216%	+$2.24M	0.03%	603
2015 Q1	$1.18M	Buy	+16,427	New	+$1.07M	0.01%	846
2014 Q3	–	Sell	-768,977	Closed	-$38.9M	–	1335
2014 Q2	$38.9M	Sell	768,977 -22,087	-3%	-$1.09M	0.43%	37
2014 Q1	$35.4M	Buy	791,064 +358	+0%	+$16.1K	0.41%	39
2013 Q4	$37.2M	Sell	790,706 -107,149	-12%	-$5.42M	0.43%	35
2013 Q3	$47.4M	Sell	897,855 -114,090	-11%	-$5.53M	0.57%	25
2013 Q2	$45.7M	Buy	+1,011,945	New	+$48M	0.56%	30

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cornerstone Capital Management Holdings's RMD Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its ResMed (RMD) stake by 9.6% in Q4 2017, buying an estimated $192K and bringing the position to 26,679 shares worth $2.26M. The position accounts for 0.02% of the portfolio, ranked #732.

Cornerstone Capital Management Holdings first reported a position in RMD in Q2 2013 and has held it in 13 quarters since. The position peaked at $47.4M in Q3 2013. 415 funds tracked by Wall St. Rank hold RMD as of Q4 2017.

Cornerstone Capital Management Holdings held 26,679 shares of ResMed worth $2.26M as of Q4 2017.
Cornerstone Capital Management Holdings bought 2,329 ResMed shares in Q4 2017, an estimated $192K.
ResMed made up 0.02% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #732 holding.
Cornerstone Capital Management Holdings first reported a position in ResMed in Q2 2013 and has held it in 13 quarters since.
Cornerstone Capital Management Holdings's ResMed position peaked at $47.4M in Q3 2013.
415 funds tracked by Wall St. Rank held ResMed as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.